Physician profile
Torre H Rhoades
NPI 1497956445
$1,472.73
in general payments reported to CMS, 2019-2025
17 companies · $534 in 2025
The $534 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $29.18 · 2021: $66.44 · 2022: $158 · 2023: $171 · 2024: $175 · 2025: $534.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $880.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $880.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $292.83 | 2021-2025 | Urolift, Barrigel |
| Intuitive Surgical, INC. | $241.89 | 2019 | |
| Urogen Pharma, INC. | $179.51 | 2025 | |
| Progenics Pharmaceuticals, INC. | $119.93 | 2025 | |
| Medtronic, INC. | $112.30 | 2025 | Interstim |
| Pfizer INC. | $99.88 | 2022 | |
| Palette Life Sciences, INC. | $80.92 | 2023 | |
| Coloplast Corp | $73.83 | 2019-2024 | |
| Janssen Biotech, INC. | $52.47 | 2019-2020 | |
| Astellas Pharma US INC | $48.91 | 2019-2023 | Myrbetriq |
| Baxter Healthcare | $44.23 | 2023 | Floseal |
| Abbvie INC. | $31.89 | 2019-2024 | |
| Valencia Technologies Corporation | $22.05 | 2023 | Ecoin Device Kit |
| Boston Scientific Corporation | $20.80 | 2025 | Watchman |
| Rochester Medical Corporation | $19.71 | 2021 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $17.68 | 2020 | |
| Astrazeneca Pharmaceuticals LP | $13.90 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Torre Rhoades listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.